CIDP (chronic inflammatory demyelinating polyneuropathy) trials in France
9 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
- Where
- Bordeaux, Creteil, Lille Cedex, Nice, Paris
- Age
- 18 years and over
- People
- 160 worldwide
- Run by
- argenx
See details and how to joinNCT07091630 · EU 2025-520805-10-00 - Phase 2/3Taking peopleEfficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Where
- Bordeaux, Bron, Le Kremlin-Bicetre, Marseille, Nice, Nimes Cedex 9, Paris, Strasbourg Cedex 2
- Age
- 18 years and over
- People
- 201 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT05327114 · EU 2023-508425-28-00 - Phase 3Taking peopleA Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
- Where
- Bordeaux, Le Kremlin Bicetre Cedex, Marseille, Nice, Paris, Strasbourg Cedex 2, Toulouse
- Age
- 18 years and over
- People
- 218 worldwide
- Run by
- argenx
See details and how to joinNCT06920004 · EU 2024-520097-36-00 - Phase 3Taking peopleA Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
- Where
- Bordeaux, Brest, Bron, Clermont-Ferrand, Libourne, Marseille, Nice, Paris, Strasbourg, Tours
- Age
- 18 years to 75 years
- People
- 256 worldwide
- Run by
- Dianthus Therapeutics
See details and how to joinNCT06858579 - Phase 3Enrolling by invitationLong-term Safety and Efficacy Study of Riliprubart in Participants With CIDP
- Where
- Bordeaux, Le Kremlin-Bicêtre, Marseille, Montpellier, Paris
- Age
- 18 years and over
- People
- 300 worldwide
- Run by
- Sanofi
See details and how to joinNCT06859099 · EU 2024-517032-22-00 - Phase 3Taking peopleA Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Where
- Le Kremlin-Bicetre, Lille Cedex, Marseille, Nice, Paris
- Age
- 18 years and over
- People
- 160 worldwide
- Run by
- Sanofi
See details and how to joinNCT06290141 · EU 2023-508338-33-00 - No phaseNot yet taking people in FranceClinical, Electrophysiological and Genetic Characteristics of Hereditary and Inflammatory Polyneuropathies in France
- Where
- Amiens, Angers, Bordeaux, Brest, Bron, Clermont-Ferrand, Dijon, Épagny, Garches, Grenoble, La Réunion, Le Kremlin-Bicêtre, Lille, Limoges, Marseille, Montpellier, Nantes, Nice, Nîmes, Paris, Reims, Rouen, Strasbourg, Toulouse, Tours
- Age
- 18 years and over
- People
- 1,000
- Run by
- Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT07851844 - Phase 3Taking peopleA Study to Evaluate the Efficacy and Safety of DNTH103 in Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
- Where
- Bordeaux, Brest, Bron, Clermont-Ferrand, Creteil, Libourne, Marseille, Nice, Paris, Strasbourg Cedex 2, Tours
- Age
- 18 years and over
- People
- 138 worldwide
- Run by
- Dianthus Therapeutics Inc.
See details and how to join2024-517529-26-00 · EU 2024-517529-26-00 - No phaseTaking peopleHizentra® in Inflammatory Neuropathies - pHeNIx Study
- Where
- Amiens, Angers, Aubagne, Bayonne, Bordeaux, Brest, Créteil, Le Kremlin-Bicêtre, Libourne, Lille, Limoges, Lyon, Marseille, Montpellier, Nancy, Nantes, Nice, Paris, Poitiers, Rennes, Rouen, Saint-Etienne, Strasbourg, Toulouse, Tours, Valence
- Age
- 18 years and over
- People
- 100
- Run by
- CSL Behring
See details and how to joinNCT04672733